Molnupiravir Will Be Another Option for Treating COVID-19

January 2022

You'll hear buzz about molnupiravir, an oral antiviral to treat COVID-19.

Molnupiravir incorporates into the RNA of the SARS-CoV-2 virus and introduces "errors" in the code...causing the virus to mutate to death.

It's 4 capsules bid for 5 days...and seems well tolerated.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote